▶ 調査レポート

アンチエイジング療法の世界市場(~2026年)

• 英文タイトル:Global Anti-Aging Therapies Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。アンチエイジング療法の世界市場(~2026年) / Global Anti-Aging Therapies Market Size, Status and Forecast 2020-2026 / MRC2-11QY10861資料のイメージです。• レポートコード:MRC2-11QY10861
• 出版社/出版日:QYResearch / 2020年11月25日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はアンチエイジング療法のグローバル市場について調査・分析したレポートです。種類別(ヒト成長ホルモン、幹細胞、胎盤、ボツリヌス毒素、ヒアルロン酸)市場規模、用途別(病院、美容院)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別アンチエイジング療法の競争状況、市場シェア
・世界のアンチエイジング療法市場:種類別市場規模 2015年-2020年(ヒト成長ホルモン、幹細胞、胎盤、ボツリヌス毒素、ヒアルロン酸)
・世界のアンチエイジング療法市場:種類別市場規模予測 2021年-2026年(ヒト成長ホルモン、幹細胞、胎盤、ボツリヌス毒素、ヒアルロン酸)
・世界のアンチエイジング療法市場:用途別市場規模 2015年-2020年(病院、美容院)
・世界のアンチエイジング療法市場:用途別市場規模予測 2021年-2026年(病院、美容院)
・北米のアンチエイジング療法市場分析:米国、カナダ
・ヨーロッパのアンチエイジング療法市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのアンチエイジング療法市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のアンチエイジング療法市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのアンチエイジング療法市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Allergan、Ipsen、Lanzhou Institute、Corneal(Allergan)、Galdermal、LG Life Science、Bohus BioTech、IMEIK、Merck、Gaoxin
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Anti-Aging Products and Therapies is the product which delay, stop or retard the aging process.
With developed in the emerging countries, the manufacturers are tend to move to lower labor cost area, but Europe and USA are still the major consumption of Anti-Aging Products and Therapies,Which occupied more than 69% of the global market in 2015.

Market Analysis and Insights: Global Anti-Aging Therapies Market
The global Anti-Aging Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Anti-Aging Therapies Scope and Market Size
Anti-Aging Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Aging Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Allergan
Ipsen
Lanzhou Institute
Corneal(Allergan)
Galdermal
LG Life Science
Bohus BioTech
IMEIK
Merck
Gaoxin

Market segment by Type, the product can be split into
Human Growth Hormone
Stem Cell
Placenta
Botulinus Toxin
Hyaluronic Acid
Market segment by Application, split into
Hospital
Beauty Parlor

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-Aging Therapies Revenue
1.4 Market by Type
1.4.1 Global Anti-Aging Therapies Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human Growth Hormone
1.4.3 Stem Cell
1.4.4 Placenta
1.4.5 Botulinus Toxin
1.4.6 Hyaluronic Acid
1.5 Market by Application
1.5.1 Global Anti-Aging Therapies Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Beauty Parlor
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Anti-Aging Therapies Market Perspective (2015-2026)
2.2 Global Anti-Aging Therapies Growth Trends by Regions
2.2.1 Anti-Aging Therapies Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anti-Aging Therapies Historic Market Share by Regions (2015-2020)
2.2.3 Anti-Aging Therapies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Anti-Aging Therapies Market Growth Strategy
2.3.6 Primary Interviews with Key Anti-Aging Therapies Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Anti-Aging Therapies Players by Market Size
3.1.1 Global Top Anti-Aging Therapies Players by Revenue (2015-2020)
3.1.2 Global Anti-Aging Therapies Revenue Market Share by Players (2015-2020)
3.1.3 Global Anti-Aging Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-Aging Therapies Market Concentration Ratio
3.2.1 Global Anti-Aging Therapies Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anti-Aging Therapies Revenue in 2019
3.3 Anti-Aging Therapies Key Players Head office and Area Served
3.4 Key Players Anti-Aging Therapies Product Solution and Service
3.5 Date of Enter into Anti-Aging Therapies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Anti-Aging Therapies Historic Market Size by Type (2015-2020)
4.2 Global Anti-Aging Therapies Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Anti-Aging Therapies Market Size by Application (2015-2020)
5.2 Global Anti-Aging Therapies Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Anti-Aging Therapies Market Size (2015-2020)
6.2 Anti-Aging Therapies Key Players in North America (2019-2020)
6.3 North America Anti-Aging Therapies Market Size by Type (2015-2020)
6.4 North America Anti-Aging Therapies Market Size by Application (2015-2020)

7 Europe
7.1 Europe Anti-Aging Therapies Market Size (2015-2020)
7.2 Anti-Aging Therapies Key Players in Europe (2019-2020)
7.3 Europe Anti-Aging Therapies Market Size by Type (2015-2020)
7.4 Europe Anti-Aging Therapies Market Size by Application (2015-2020)

8 China
8.1 China Anti-Aging Therapies Market Size (2015-2020)
8.2 Anti-Aging Therapies Key Players in China (2019-2020)
8.3 China Anti-Aging Therapies Market Size by Type (2015-2020)
8.4 China Anti-Aging Therapies Market Size by Application (2015-2020)

9 Japan
9.1 Japan Anti-Aging Therapies Market Size (2015-2020)
9.2 Anti-Aging Therapies Key Players in Japan (2019-2020)
9.3 Japan Anti-Aging Therapies Market Size by Type (2015-2020)
9.4 Japan Anti-Aging Therapies Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Anti-Aging Therapies Market Size (2015-2020)
10.2 Anti-Aging Therapies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-Aging Therapies Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-Aging Therapies Market Size by Application (2015-2020)

11 India
11.1 India Anti-Aging Therapies Market Size (2015-2020)
11.2 Anti-Aging Therapies Key Players in India (2019-2020)
11.3 India Anti-Aging Therapies Market Size by Type (2015-2020)
11.4 India Anti-Aging Therapies Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Anti-Aging Therapies Market Size (2015-2020)
12.2 Anti-Aging Therapies Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-Aging Therapies Market Size by Type (2015-2020)
12.4 Central & South America Anti-Aging Therapies Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Anti-Aging Therapies Introduction
13.1.4 Allergan Revenue in Anti-Aging Therapies Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Ipsen
13.2.1 Ipsen Company Details
13.2.2 Ipsen Business Overview
13.2.3 Ipsen Anti-Aging Therapies Introduction
13.2.4 Ipsen Revenue in Anti-Aging Therapies Business (2015-2020)
13.2.5 Ipsen Recent Development
13.3 Lanzhou Institute
13.3.1 Lanzhou Institute Company Details
13.3.2 Lanzhou Institute Business Overview
13.3.3 Lanzhou Institute Anti-Aging Therapies Introduction
13.3.4 Lanzhou Institute Revenue in Anti-Aging Therapies Business (2015-2020)
13.3.5 Lanzhou Institute Recent Development
13.4 Corneal(Allergan)
13.4.1 Corneal(Allergan) Company Details
13.4.2 Corneal(Allergan) Business Overview
13.4.3 Corneal(Allergan) Anti-Aging Therapies Introduction
13.4.4 Corneal(Allergan) Revenue in Anti-Aging Therapies Business (2015-2020)
13.4.5 Corneal(Allergan) Recent Development
13.5 Galdermal
13.5.1 Galdermal Company Details
13.5.2 Galdermal Business Overview
13.5.3 Galdermal Anti-Aging Therapies Introduction
13.5.4 Galdermal Revenue in Anti-Aging Therapies Business (2015-2020)
13.5.5 Galdermal Recent Development
13.6 LG Life Science
13.6.1 LG Life Science Company Details
13.6.2 LG Life Science Business Overview
13.6.3 LG Life Science Anti-Aging Therapies Introduction
13.6.4 LG Life Science Revenue in Anti-Aging Therapies Business (2015-2020)
13.6.5 LG Life Science Recent Development
13.7 Bohus BioTech
13.7.1 Bohus BioTech Company Details
13.7.2 Bohus BioTech Business Overview
13.7.3 Bohus BioTech Anti-Aging Therapies Introduction
13.7.4 Bohus BioTech Revenue in Anti-Aging Therapies Business (2015-2020)
13.7.5 Bohus BioTech Recent Development
13.8 IMEIK
13.8.1 IMEIK Company Details
13.8.2 IMEIK Business Overview
13.8.3 IMEIK Anti-Aging Therapies Introduction
13.8.4 IMEIK Revenue in Anti-Aging Therapies Business (2015-2020)
13.8.5 IMEIK Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Anti-Aging Therapies Introduction
13.9.4 Merck Revenue in Anti-Aging Therapies Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Gaoxin
13.10.1 Gaoxin Company Details
13.10.2 Gaoxin Business Overview
13.10.3 Gaoxin Anti-Aging Therapies Introduction
13.10.4 Gaoxin Revenue in Anti-Aging Therapies Business (2015-2020)
13.10.5 Gaoxin Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Anti-Aging Therapies Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-Aging Therapies Revenue
Table 3. Ranking of Global Top Anti-Aging Therapies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-Aging Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Human Growth Hormone
Table 6. Key Players of Stem Cell
Table 7. Key Players of Placenta
Table 8. Key Players of Botulinus Toxin
Table 9. Key Players of Hyaluronic Acid
Table 10. Global Anti-Aging Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Anti-Aging Therapies Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Anti-Aging Therapies Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Anti-Aging Therapies Market Share by Regions (2015-2020)
Table 14. Global Anti-Aging Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Anti-Aging Therapies Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Anti-Aging Therapies Market Growth Strategy
Table 20. Main Points Interviewed from Key Anti-Aging Therapies Players
Table 21. Global Anti-Aging Therapies Revenue by Players (2015-2020) (Million US$)
Table 22. Global Anti-Aging Therapies Market Share by Players (2015-2020)
Table 23. Global Top Anti-Aging Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Aging Therapies as of 2019)
Table 24. Global Anti-Aging Therapies by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Anti-Aging Therapies Product Solution and Service
Table 27. Date of Enter into Anti-Aging Therapies Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 30. Global Anti-Aging Therapies Market Size Share by Type (2015-2020)
Table 31. Global Anti-Aging Therapies Revenue Market Share by Type (2021-2026)
Table 32. Global Anti-Aging Therapies Market Size Share by Application (2015-2020)
Table 33. Global Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 34. Global Anti-Aging Therapies Market Size Share by Application (2021-2026)
Table 35. North America Key Players Anti-Aging Therapies Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Anti-Aging Therapies Market Share (2019-2020)
Table 37. North America Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 38. North America Anti-Aging Therapies Market Share by Type (2015-2020)
Table 39. North America Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 40. North America Anti-Aging Therapies Market Share by Application (2015-2020)
Table 41. Europe Key Players Anti-Aging Therapies Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Anti-Aging Therapies Market Share (2019-2020)
Table 43. Europe Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Anti-Aging Therapies Market Share by Type (2015-2020)
Table 45. Europe Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Anti-Aging Therapies Market Share by Application (2015-2020)
Table 47. China Key Players Anti-Aging Therapies Revenue (2019-2020) (Million US$)
Table 48. China Key Players Anti-Aging Therapies Market Share (2019-2020)
Table 49. China Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 50. China Anti-Aging Therapies Market Share by Type (2015-2020)
Table 51. China Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 52. China Anti-Aging Therapies Market Share by Application (2015-2020)
Table 53. Japan Key Players Anti-Aging Therapies Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Anti-Aging Therapies Market Share (2019-2020)
Table 55. Japan Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Anti-Aging Therapies Market Share by Type (2015-2020)
Table 57. Japan Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Anti-Aging Therapies Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Anti-Aging Therapies Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Anti-Aging Therapies Market Share (2019-2020)
Table 61. Southeast Asia Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Anti-Aging Therapies Market Share by Type (2015-2020)
Table 63. Southeast Asia Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Anti-Aging Therapies Market Share by Application (2015-2020)
Table 65. India Key Players Anti-Aging Therapies Revenue (2019-2020) (Million US$)
Table 66. India Key Players Anti-Aging Therapies Market Share (2019-2020)
Table 67. India Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 68. India Anti-Aging Therapies Market Share by Type (2015-2020)
Table 69. India Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 70. India Anti-Aging Therapies Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Anti-Aging Therapies Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Anti-Aging Therapies Market Share (2019-2020)
Table 73. Central & South America Anti-Aging Therapies Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Anti-Aging Therapies Market Share by Type (2015-2020)
Table 75. Central & South America Anti-Aging Therapies Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Anti-Aging Therapies Market Share by Application (2015-2020)
Table 77. Allergan Company Details
Table 78. Allergan Business Overview
Table 79. Allergan Product
Table 80. Allergan Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 81. Allergan Recent Development
Table 82. Ipsen Company Details
Table 83. Ipsen Business Overview
Table 84. Ipsen Product
Table 85. Ipsen Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 86. Ipsen Recent Development
Table 87. Lanzhou Institute Company Details
Table 88. Lanzhou Institute Business Overview
Table 89. Lanzhou Institute Product
Table 90. Lanzhou Institute Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 91. Lanzhou Institute Recent Development
Table 92. Corneal(Allergan) Company Details
Table 93. Corneal(Allergan) Business Overview
Table 94. Corneal(Allergan) Product
Table 95. Corneal(Allergan) Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 96. Corneal(Allergan) Recent Development
Table 97. Galdermal Company Details
Table 98. Galdermal Business Overview
Table 99. Galdermal Product
Table 100. Galdermal Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 101. Galdermal Recent Development
Table 102. LG Life Science Company Details
Table 103. LG Life Science Business Overview
Table 104. LG Life Science Product
Table 105. LG Life Science Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 106. LG Life Science Recent Development
Table 107. Bohus BioTech Company Details
Table 108. Bohus BioTech Business Overview
Table 109. Bohus BioTech Product
Table 110. Bohus BioTech Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 111. Bohus BioTech Recent Development
Table 112. IMEIK Business Overview
Table 113. IMEIK Product
Table 114. IMEIK Company Details
Table 115. IMEIK Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 116. IMEIK Recent Development
Table 117. Merck Company Details
Table 118. Merck Business Overview
Table 119. Merck Product
Table 120. Merck Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 121. Merck Recent Development
Table 122. Gaoxin Company Details
Table 123. Gaoxin Business Overview
Table 124. Gaoxin Product
Table 125. Gaoxin Revenue in Anti-Aging Therapies Business (2015-2020) (Million US$)
Table 126. Gaoxin Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Aging Therapies Market Share by Type: 2020 VS 2026
Figure 2. Human Growth Hormone Features
Figure 3. Stem Cell Features
Figure 4. Placenta Features
Figure 5. Botulinus Toxin Features
Figure 6. Hyaluronic Acid Features
Figure 7. Global Anti-Aging Therapies Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Beauty Parlor Case Studies
Figure 10. Anti-Aging Therapies Report Years Considered
Figure 11. Global Anti-Aging Therapies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Anti-Aging Therapies Market Share by Regions: 2020 VS 2026
Figure 13. Global Anti-Aging Therapies Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Anti-Aging Therapies Market Share by Players in 2019
Figure 16. Global Top Anti-Aging Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Aging Therapies as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Anti-Aging Therapies Revenue in 2019
Figure 18. North America Anti-Aging Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Anti-Aging Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Anti-Aging Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Anti-Aging Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Anti-Aging Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Anti-Aging Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Anti-Aging Therapies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed